Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Fresenius SE & Co. (FSNUY : OTC)

• Company Description    Fresenius SE & Co is a health care company. It offers products and services for dialysis, hospitals and outpatient treatment. The company's business segment consists of Fresenius Medical Care is engaged in treating with chronic kidney failure; Fresenius Helios is a hospital operator; Fresenius Kabi supplies essential drugs, clinical nutrition products, medical devices and services and Fresenius Vamed plans, develops and manages healthcare facilities. Fresenius SE & Co is headquartered in Bad Homburg, Germany. Number of Employees: 176,486

• Price / Volume Information    Yesterday's Closing Price: $15.10 Daily Weekly Monthly 20 Day Moving Average: 26,812 shares Shares Outstanding: 2,252.95 (millions) Market Capitalization: $34,019.53 (millions) Beta: 0.75 52 Week High: $31.99 52 Week Low: $9.78 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 8.17% 9.58% 12 Week 8.24% 7.90% Year To Date 5.37% 5.17%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL Else-Kroner-Strasse 1 - Bad Homburg,2M 61352 DEU ph: 49-6172-608-2485 fax: - ir-fre@fresenius.com http://www.fresenius.com

• General Corporate Information    Officers Frank Appe - Chief Executive Officer Michael Sen - Chairman Sara Hennicken - Chief Financial Officer Robert Moller - Director Michael Moser - Director Peer Information Fresenius SE & Co. (CMTI) Fresenius SE & Co. (CMWLQ) Fresenius SE & Co. (AHG.) Fresenius SE & Co. (ROIX) Fresenius SE & Co. (M.DCE) Fresenius SE & Co. (DHSM) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-OUTP/HM CRE Sector: Medical CUSIP: 35804M105 SIC: 3841 Fiscal Year Fiscal Year End: December Last Reported Quarter: 12/01/25 Next Expected EPS Date: 05/06/26 Share - Related Items Shares Outstanding: 2,252.95 Most Recent Split Date: (:1) Beta: 0.75 Market Capitalization: $34,019.53 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 1.25% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.19 Current Fiscal Year EPS Consensus Estimate: $1.08 Payout Ratio: 0.21 Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio: 0.04 Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 05/06/26

• Fundamental Ratios P/E Current FY Estimate: 13.98 Trailing 12 Months: 15.41 PEG Ratio: - Price Ratios Price/Book: - Price/Cash Flow: 11.70 Price / Sales: 1.33 EPS Growth vs. Year Ago Period: 55.56% vs. Previous Quarter: 21.74% Sales Growth vs. Year Ago Period: 15.54% vs. Previous Quarter: 8.23% ROE 12/31/25 - 10.38 09/30/25 - 9.72 06/30/25 - 9.33 ROA 12/31/25 - 4.76 09/30/25 - 4.48 06/30/25 - 4.31 Current Ratio 12/31/25 - - 09/30/25 - 1.26 06/30/25 - 1.31 Quick Ratio 12/31/25 - - 09/30/25 - 0.99 06/30/25 - 1.00 Operating Margin 12/31/25 - 8.81 09/30/25 - 8.58 06/30/25 - 8.30 Net Margin 12/31/25 - 5.71 09/30/25 - 5.26 06/30/25 - 5.09 Pre-Tax Margin 12/31/25 - - 09/30/25 - 8.86 06/30/25 - 8.62 Book Value 12/31/25 - - 09/30/25 - - 06/30/25 - - Inventory Turnover 12/31/25 - - 09/30/25 - 6.33 06/30/25 - 6.27 Debt-to-Equity 12/31/25 - - 09/30/25 - 0.49 06/30/25 - 0.49 Debt-to-Capital 12/31/25 - - 09/30/25 - 33.10 06/30/25 - 32.96

Powered by Zacks Investment Research ©